Compile Data Set for Download or QSAR
maximum 50k data
Found 175 of ic50 data for polymerid = 1027,1028,50005737
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481111(CHEMBL566647)
Affinity DataIC50:  0.400nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481110(CHEMBL586043)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481112(CHEMBL567711)
Affinity DataIC50:  1.80nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481108(CHEMBL566665)
Affinity DataIC50:  2.40nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  5nMAssay Description:Inhibition of Escherichia coli FabI using 2-dodecenoyl-CoA as substrate at pH 8More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481114(CHEMBL566043)
Affinity DataIC50:  7nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481103(CHEMBL583197)
Affinity DataIC50:  9nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594241(CHEMBL5196531)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594239(CHEMBL5200486)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594240(CHEMBL5202156)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594237(CHEMBL5190373)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594238(CHEMBL5205550)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50594236(CHEMBL5190472)
Affinity DataIC50: <10nMAssay Description:Inhibition of Escherichia coli FabL assessed as measuring NADH consumption rateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481102(CHEMBL567520)
Affinity DataIC50:  12nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481097(CHEMBL565647)
Affinity DataIC50:  14nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481105(CHEMBL567313)
Affinity DataIC50:  14nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481100(CHEMBL576646)
Affinity DataIC50:  16nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481106(CHEMBL571088)
Affinity DataIC50:  17nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481109(CHEMBL566666)
Affinity DataIC50:  24nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481094(CHEMBL567931)
Affinity DataIC50:  25nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae)
Glaxosmithkline

LigandPNGBDBM8735((2E)-N-[(1,2-dimethyl-1H-indol-3-yl)methyl]-N-meth...)
Affinity DataIC50:  25nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481101(CHEMBL567084)
Affinity DataIC50:  25nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481096(CHEMBL567710)
Affinity DataIC50:  29nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481098(CHEMBL567311)
Affinity DataIC50:  30nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8735((2E)-N-[(1,2-dimethyl-1H-indol-3-yl)methyl]-N-meth...)
Affinity DataIC50:  30nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481099(CHEMBL570866)
Affinity DataIC50:  39nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481113(CHEMBL568359)
Affinity DataIC50:  55nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8734((2E)-N-methyl-N-[(2-methyl-1H-indol-3-yl)methyl]-3...)
Affinity DataIC50: <60nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481092(CHEMBL566655)
Affinity DataIC50:  64nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8733((2E)-N-methyl-N-[(1-methyl-1H-indol-3-yl)methyl]-3...)
Affinity DataIC50:  70nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8736((2E)-N-methyl-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naph...)
Affinity DataIC50: <70nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae)
Glaxosmithkline

LigandPNGBDBM8736((2E)-N-methyl-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naph...)
Affinity DataIC50:  70nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae)
Glaxosmithkline

LigandPNGBDBM8734((2E)-N-methyl-N-[(2-methyl-1H-indol-3-yl)methyl]-3...)
Affinity DataIC50:  130nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481093(CHEMBL566443)
Affinity DataIC50:  136nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)
Affinity DataIC50:  139nMAssay Description:Inhibition of Escherichia coli FabI assessed as effect on NAD(P)H consumptionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)
Affinity DataIC50:  150nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481095(CHEMBL567910)
Affinity DataIC50:  330nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae)
Glaxosmithkline

LigandPNGBDBM8733((2E)-N-methyl-N-[(1-methyl-1H-indol-3-yl)methyl]-3...)
Affinity DataIC50:  390nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  430nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  430nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  430nMpH: 6.5 T: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Bacillus subtilis (strain 168))
University Of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  500nMAssay Description:Inhibition of Bacillus anthracis Enoyl ACP reductaseMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Haemophilus influenzae)
Glaxosmithkline

LigandPNGBDBM8732((2E)-N-methyl-N-[(1-methyl-1H-indol-2-yl)methyl]-3...)
Affinity DataIC50:  560nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Bacillus subtilis (strain 168))
University Of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50377104(CHEMBL259629)
Affinity DataIC50:  700nMAssay Description:Inhibition of Bacillus anthracis Enoyl ACP reductaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Bacillus subtilis (strain 168))
University Of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50377084(CHEMBL260770)
Affinity DataIC50:  800nMAssay Description:Inhibition of Bacillus anthracis Enoyl ACP reductaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Bacillus subtilis (strain 168))
University Of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50377089(CHEMBL261638)
Affinity DataIC50:  800nMAssay Description:Inhibition of Bacillus anthracis Enoyl ACP reductaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50481104(CHEMBL566654)
Affinity DataIC50:  840nMAssay Description:Inhibition of Escherichia coli FabIMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8726(5-chloro-2-(2,4-dichlorophenoxy)phenol | CHEMBL849...)
Affinity DataIC50:  900nMAssay Description:Inhibition of Escherichia coli enoyl-ACP reductase FabIMore data for this Ligand-Target Pair
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Bacillus subtilis (strain 168))
University Of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50377090(CHEMBL261348)
Affinity DataIC50:  1.10E+3nMAssay Description:Inhibition of Bacillus anthracis Enoyl ACP reductaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEnoyl-[acyl-carrier-protein] reductase [NADH] FabI(Escherichia coli)
Affinium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM8748(1-[(4-phenylphenyl)methyl]-4-(thiophen-3-yl)-1H-im...)
Affinity DataIC50:  1.18E+3nMT: 2°CAssay Description:Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each e...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 175 total ) | Next | Last >>
Jump to: